R. Rosell

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

R. Rosell, José Gómez‐Codina, Carlos Camps et al. · New England Journal of Medicine · 1994 · 1.3K citations · Full text

Targeting RET in Patients With <i>RET</i>-Rearranged Lung Cancers: Results From the Global, Multicenter <i>RET</i> Registry

Oliver Gautschi, Julie Milia, Thomas Filleron et al. · Journal of Clinical Oncology · 2017 · 349 citations · Full text

ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association

J.-Y. Douillard, R. Rosell, M DELENA et al. · Journal of Clinical Oncology · 2005 · 161 citations

Iiia Nsclc Pts, Surgical Oncology, Cancer Management +23

Erlotinib versus chemotherapy (CT) in advanced non-small cell lung cancer (NSCLC) patients (p) with epidermal growth factor receptor (EGFR) mutations: Interim results of the European Erlotinib Versus Chemotherapy (EURTAC) phase III randomized trial.

R. Rosell, R. Gervais, A. Vergnenègre et al. · Journal of Clinical Oncology · 2011 · 148 citations

Advanced Nsclc P, Medicine, Phase Iii +14

The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification

William D. Travis, Élisabeth Brambilla, Masayuki Noguchi et al. · Journal of Thoracic Oncology · 2009 · 86 citations

Advanced Lung Disease, Medicine, Multiple Pulmonary Nodule +6